When was United Therapeutics founded?

United Therapeutics was founded in 1998.

Where is United Therapeutics located?

United Therapeutics is headquartered in Silver Spring, United States. It is registered at Silver Spring, Maryland.

Who is the current CEO of United Therapeutics?

Martine Rothblatt of United Therapeutics.

How many employees does United Therapeutics have?

As of Aug 31, 2026, the latest employee count at United Therapeutics is 1575.

What is the annual revenue of United Therapeutics?

Annual revenue of United Therapeutics is more than $1B as on Dec 31, 2025

Where does United Therapeutics rank among its competitors?

United Therapeutics ranks 15th amongst 1847 active competitors, of which 95 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was AstraZeneca, which secured $6.05M in Jul, 2025.

Who are the top competitors of United Therapeutics?

United Therapeutics' top competitors include AbbVie, Gilead and Amgen. Among them, AstraZeneca secured the most recent funding round in July, 2025.

United Therapeutics - 2026 Company Profile, Team, Funding, Competitors & Financials

Company Details

United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of innovative products to address the unmet medical needs of patients with chronic and life-threatening conditions. The company has 5 approved products in the market. The main disease areas of focus are cardiovascular, infectious diseases and cancer&nbsp. In 2022, the company recorded annual revenues of $1.98B and a net profit of $0.73B.

Website: www.unither.com/
Email ID: *****@unither.com
Registered Address: Silver Spring, Maryland

Key Metrics

Founded Year

1998

Location

Silver Spring, United States

Stage

Public

Investors

Tekla Capital Management & 5 more

Ranked

15^th among 1847 active competitors

Annual Revenue

$1B+ as on Dec 31, 2025

Employee Count

1,575 as on Aug 31, 2026

Investment & Acquisitions

BETA & 8 more

Similar Companies

AbbVie & 1875 more

Exit Details

Public

View United Therapeutics' full profile

United Therapeutics is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
United Therapeutics Corp CIN: 1082554 , United States, Active	Jun 25, 1996	$1B+ (As on Dec 31, 2025)	1168 (As on Dec 31, 2023)	-
United Therapeutics Corporation CIN: 521984749 , United States, Active	Dec 26, 999	-	1291 (As on Dec 31, 2024)	-

United Therapeutics got listed on Jun 17, 1999.

Click here to take a look at United Therapeutics's IPO in detail

United Therapeutics is a funded company. United Therapeutics has 6 institutional investors.

View details of United Therapeutics's funding rounds and investors

The founders of United Therapeutics is Martine Rothblatt.

Here are the details of United Therapeutics' key team members:

Martine Rothblatt: Founder & CEO of United Therapeutics and founder of 3 other companies, STG Partners, SiriusXM Dealer and Lung Biotechnology.
Contact Info: 2 email addresses

View details of United Therapeutics's Founder profiles and Board Members

United Therapeutics' employee count trend

United Therapeutics has 1,575 employees as of Aug 26. Here is United Therapeutics's employee count trend over the years:

Employee count trend for United Therapeutics

Uncover United Therapeutics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of United Therapeutics include AbbVie, Gilead and Amgen. Here is the list of Top 10 competitors of United Therapeutics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	AbbVie 2012, Chicago (United States), Public	Research-based biopharmaceutical company	$14.7B	Berkshire Hathaway, Alcor Fund & 9 others	83/100
2nd	Gilead 1987, Foster City (United States), Acquired	Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others	-	BB Biotech, Jindal ventures & 17 others	81/100
3rd	Amgen 1980, Thousand Oaks (United States), Public	Developer of pharmaceutical products for treating multiple diseases	-	Digital Pharma Lab, Amgen Business Development ... & 11 others	79/100
4th	AstraZeneca 1999, Cambridge (United Kingdom), Public	Developer of pharmaceutical medicines for oncology and various chronic diseases	-	Digital Pharma Lab, Columbia Capital & 13 others	76/100
5th	Lilly 1876, Indianapolis (United States), Public	Developer of traditional pharmaceutical medicines	-	Alcor Fund, Digital Pharma Lab & 11 others	75/100
6th	Johnson & Johnson 1886, New Brunswick (United States), Public	Manufacturer and supplier of beauty care products, medical devices, and pharmaceutical products	-	Western Technology Investment, Alcor Fund ... & 16 others	74/100
7th	Roivant Sciences 2014, New York City (United States), Public	Developer of therapeutics to treat neurology, oncology, rare, and endocrinology based diseases	$1.3B	SoftBank Vision Fund, NovaQuest Capital Management ... & 8 others	72/100
8th	Novartis 1996, Basel (Switzerland), Acquired	R&D focused on manufacturing of drugs for multiple therapeutic areas	-	Digital Pharma Lab, Atlas Venture & 9 others	71/100
9th	Roche 1896, Basel (Switzerland), Public	Developer of pharmaceuticals and diagnostics kits	-	Gilde Healthcare, SoftBank Group & 11 others	70/100
10th	Genentech 1976, San Francisco (United States), Acquired	R&D company focused on manufacturing drugs for multiple therapeutic areas	$72.5M	Ignite 500, The Column Group & 4 others	68/100
15th	United Therapeutics 1998, Silver Spring (United States), Public	Specialty company developing treatment for chronic and life-threatening diseases	-	Tekla Capital Management, Ridgeback Capital Management ... & 4 others	66/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on United Therapeutics's competitors? Click here to see the top ones

United Therapeutics has made 5 investments in companies including BETA and TAI Diagnostics. United Therapeutics has also acquired 4 companies including Miromatrix and IVIVA Medical.

Here is the list of investments & acquisitions:

Filter this list

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Oct 24, 2024	Investments	BETA	2012	South Burlington (United States)
Oct 30, 2023	Acquisition	Miromatrix	2009	Eden Prairie (United States)
Oct 01, 2023	Acquisition	IVIVA Medical	2013	Beverly (United States)

Want to know more about where corporates are investing? Sign up today!

See all investments and acquisitions by United Therapeutics

Here is the latest report on United Therapeutics's sector:

Free

Diversified Pharmaceuticals - Sector Report

Edition: August, 2026 (58 Pages)

View all reports related to United Therapeutics

Media has covered United Therapeutics for a total of 69 events in the last 1 year, 47 of them have been about company updates and 5 about people movement.